Su1221 COMPARISON OF EFFECTIVENESS AND SAFETY OF LUMEN-APPOSING METAL STENT AND ANTIMIGRATING TUBULAR SELF-EXPANDABLE METAL STENT FOR ENDOSCOPIC ULTRASOUND-GUIDED GALLBLADDER DRAINAGE IN HIGH SURGICAL RISK PATIENTS WITH ACUTE CHOLECYSTITIS: PILOT STUDY

2019 ◽  
Vol 89 (6) ◽  
pp. AB322
Author(s):  
Sung Hyun Cho ◽  
Dongwook Oh ◽  
Tae Jun Song ◽  
Do Hyun Park ◽  
Sung Koo Lee ◽  
...  
2017 ◽  
Vol 05 (11) ◽  
pp. E1100-E1103 ◽  
Author(s):  
Andrea Anderloni ◽  
Fabia Attili ◽  
Alessandro Sferrazza ◽  
Mihai Rimbaș ◽  
Guido Costamagna ◽  
...  

Abstract Background and study aims We report our experience in endoscopic ultrasound-guided gallbladder drainage performed emergently in 4 prohibitive surgical risk patients with concurrent coagulopathy or on anticoagulant therapy using an electrocautery enhanced lumen apposing self expanding metal stent (LA-SEMS).


Endoscopy ◽  
2019 ◽  
Vol 52 (02) ◽  
pp. 96-106 ◽  
Author(s):  
Babu P. Mohan ◽  
Shahab R. Khan ◽  
Sushruth Trakroo ◽  
Suresh Ponnada ◽  
Mahendran Jayaraj ◽  
...  

Abstract Background Endoscopic transpapillary gallbladder drainage (ETGBD) and endoscopic ultrasound-guided gallbladder drainage (EUSGBD) are alternatives to percutaneous gallbladder drainage (PCGBD) for patients with acute cholecystitis who are unfit for surgery. Data comparing these modalities are limited and have reported conflicting results. Methods We searched multiple databases from inception to May 2019 to identify studies that reported on ETGBD, EUSGBD, and PCGBD in the management of acute cholecystitis in patients with a high surgical risk. Aims were to compare the pooled rates of technical success, clinical success, adverse events, and disease recurrence. Results 1223 patients (22 studies), 557 patients (14 studies), and 13 351 patients (46 studies) were treated by ETGBD, EUSGBD, and PCGBD, respectively. The pooled technical and clinical successes were: ETGBD 83 % (95 % confidence interval [CI] 80.1 – 85.5, I 2 = 29) and 88.1 % (95 %CI 83.6 – 91.4, I 2 = 50), respectively; EUSGBD 95.3 % (95 %CI 92.8 – 96.9, I 2 = 0) and 96.7 % (95 %CI 94.0 – 98.2, I 2 = 0), respectively; and PCGBD 98.7 % (95 %CI 98.0 – 99.1, I 2 = 0) and 89.3 % (95 %CI 86.6 – 91.5, I 2 = 84), respectively. Clinical success with EUSGBD was significantly superior to the other approaches. All complications were comparable between the groups. Pancreatitis occurred with ETGBD in 5.1 % (95 %CI 3.5 – 7.3), whereas bleeding and perforation occurred with EUSGBD in 4.3 % (95 %CI 2.7 – 6.8) and 3.7 % (95 %CI 2.3 – 6.0), respectively. Stent migration occurred with PCGBD in 7.4 % (95 %CI 5.5 – 10.0). Conclusion EUSGBD demonstrated better clinical success than ETGBD and PCGBD in the management of acute cholecystitis patients at high surgical risk.


2017 ◽  
Vol 86 (4) ◽  
pp. 636-643 ◽  
Author(s):  
Markus Dollhopf ◽  
Alberto Larghi ◽  
Uwe Will ◽  
Mihai Rimbaş ◽  
Andrea Anderloni ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document